Mass General, CRISPR Therapeutics to Develop Cancer Therapies – GenomeWeb
|
Mass General, CRISPR Therapeutics to Develop Cancer Therapies
GenomeWeb NEW YORK (GenomeWeb) – CRISPR Therapeutics and Massachusetts General Hospital Cancer Center (MGHCC) announced today that they have signed a two-year research collaboration and license option agreement to develop novel T-cell therapies for … |
